Viragen, Inc.
U.K. investment firm reiterates buy recommendation on pharmaceuticals company
Published in Elder Law Weekly, August 3rd, 2005
In a research update distributed to investment professionals, senior research analyst Peter Cartwright, stated, "The Avian project has made excellent progress over the past 12 months and is fast reaching the point where it will be a material factor in the share price. We expect additional milestones and partnering opportunities to drive the near-term valuation." Cartwright's report is not intended for private...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
Source: Elder Law Weekly (2005-08-03)
More Articles from Elder Law Weekly
- Alfred Hospital, Melbourne
Diet rich in omega-3 PUFA reverses age-associated omega-3:omega-6 PUFA imbalance - BlueCross BlueShield of Tennessee
Health insurance provider announces partnership to utilize technology - Care Level Management Direct
Contract awarded to provide in-home physician care to elderly patients - Royal Free & Univ. College Medical School, London
ADH1C genotype modifies link between alcohol consumption and CHD risk - Univ. of California, Santa Barbara
Discovery could lead to new types of Alzheimer drugs - Adenosine Therapeutics, LLC
Phase I/II grant awarded to prevent cardiac reperfusion injury - More from this issue of Elder Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
